Illumina CEO expects US antitrust review of PacBio merger to conclude ahead of UK decision
Illumina Chief Executive Officer Francis deSouza said the company continues to provide information to antitrust regulators about its proposed acquisition of Pacific Biosciences and he expects the US review to conclude...To view the full article, register now.
Already a subscriber? Click here to view full article